How will Meta's nuclear deal impact AI energy use?
Why did Nvidia regain title as top valued company?
What effect will Trump's steel and aluminum tariffs have?
How is South Korea's new president shaping trade policy?
Why are auto makers concerned about China's mineral export curbs?
What caused CrowdStrike's revenue forecast to weaken?
How are US job openings rising amid trade tensions?
Regeneron's Obesity Trial With Novo Nordisk's Wegovy Hits Lean Target
benzinga.com/news/health-care/25/06/45726872/regeneron-experimental-weight-loss-drug-with-novo-nordisks-wegovy-helps-preserve-lean-mass-in-mi
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Monday released interim results from the ongoing Phase 2 COURAGE trial.
The company is investigating novel combinations of Novo Nordisk A/S (NYSE:NVO) Wegovy (semaglutide) (GLP-1 receptor agonist) and trevogrumab (anti-GDF8/anti-myostatin)…
This story appeared on benzinga.com, 2025-06-02 15:59:16.